(2019). Corrigendum to: Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial. Eur Heart J.
Chicago-tyylinen lähdeviittaus"Corrigendum To: Uninterrupted Edoxaban Vs. Vitamin K Antagonists for Ablation of Atrial Fibrillation: The ELIMINATE-AF Trial." Eur Heart J 2019.
MLA-viite"Corrigendum To: Uninterrupted Edoxaban Vs. Vitamin K Antagonists for Ablation of Atrial Fibrillation: The ELIMINATE-AF Trial." Eur Heart J 2019.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.